MDGL MADRIGAL PHARMACEUTICALS INC Earnings Reports 8-K Filing 2025 - Earnings Update Madrigal Pharmaceuticals reported preliminary net sales of $100-$103 million for Q4 2024 and $177-$180 million for the full year, with approximately $931 million in cash and equivalents as of December 31, 2024.Get access to all SEC 8-K filings of the MADRIGAL PHARMACEUTICALS INC